Ro01-6128

Ro01-6128 is a pharmacological compound that belongs to the class of benzodiazepine drugs. It is a psychoactive drug that possesses anxiolytic, anticonvulsant, hypnotic, sedative, skeletal muscle relaxant, and amnestic properties.

Pharmacology[edit]

Ro01-6128 is a benzodiazepine receptor agonist. It binds to the GABA (gamma-aminobutyric acid) receptors in the brain, enhancing the effects of this inhibitory neurotransmitter and leading to sedative and anxiolytic effects.

Medical Uses[edit]

Ro01-6128 is primarily used for the treatment of anxiety disorders, insomnia, seizures, and muscle spasms. It is also used as a premedication for medical or dental procedures to induce sedation and amnesia.

Side Effects[edit]

Common side effects of Ro01-6128 include drowsiness, dizziness, and impaired coordination. Long-term use can lead to physical dependence and withdrawal symptoms upon discontinuation.

History[edit]

Ro01-6128 was first synthesized in the 1970s by Roche, a Swiss multinational healthcare company. It is part of the larger family of benzodiazepine drugs, which were first discovered in the 1950s.

Benzodiazipines[edit]

Anticonvulsants Drugs[edit]

Anticonvulsants, and Benzodiazepines]

Template:Anxiolytics

Sedatives and Hypnotics[edit]

Barbiturates

Benzodiazepines
- Diazepam
- Estazolam
- Flurazepam
- Quazepam
- Temazepam
- Triazolam

Benzodiazepine Receptor Agonists

Herbals
- Chamomile (Matricaria recutita)
- Hops (Humulus lupulus)
- Lavender (Lavandula angustifolia)
- Passionflower (Passiflora incarnata)
- Valerian (Valeriana officinalis)

Melatonin and its Analogues

Miscellaneous Agents

- Buspirone
- Chloral hydrate
- Doxepin
- Meprobamate
- Sodium Oxybate (Narcolepsy Agent)
- Suvorexant

Muscle relaxants

Ro01-6128

Navigation-> Medicine - Wellness - Encyclopedia - Health topics - Diseases - Drugs - Gray's Anatomy - W8MD diet - Ketogenic diet - Recipes

Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Translate page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian